Carsten is a Hematologist Chief Physician and Associate Professor at Copenhagen University with +10 years hands-on experience in hematology research laboratories across Europe and US. He is chairing the Nordic CLL Study Group and heading the CLL research laboratory and clinical research programme at Rigshospitalet, Copenhagen, Denmark. Combining genetic and functional characterization of CLL and microenvironmental cells, MRD testing and diagnostic work up for CLL based on the EuroMRD and ERIC collaborations, along with epidemiological studies. Impacting current practice in CLL, co-authoring ESMO guidelines, TP53 guidelines, flowcytometry- and MRD-guidelines for CLL in addition to 100 peer-reviewed publications. Founding member for the clinical GAIA/CLL13, VISION/HO141, HO158, HO159 and CLL17 trials, thus leading the way for testing targeted therapy in CLL. Founder of the PreVent-ACaLL phase 2-3 trial, the first Machine Learning based clinical trial in CLL. Thus, applying a uniquely strong background across all the disciplines needed for translational research in CLL feeding into extended decision matrices for lymphoid malignancies based on medical Artificial Intelligence for precision medicine.